Can a short video make nerve pain treatment more accessible for minorities?
NCT ID NCT05896202
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether showing Black and Hispanic adults with long-term nerve pain a short, culturally sensitive video about nerve stimulation techniques could improve their understanding and expectations. Twenty-eight participants watched a video and reviewed educational materials. The goal was to find better ways to inform and include underrepresented groups in future research on treatments like nerve stimulation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- educational videos and materials about nerve stimulation techniques
- What this could lead to
- If successful, this approach could help make nerve stimulation treatments more accessible and acceptable for underrepresented groups.
- What could go wrong
- This is a small, completed study focused on education and expectations, not on treating pain itself. The results may not apply to larger or more diverse populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
28 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Jul 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. between the ages of 18-80 years 2. neuropathic pain lasting longer than 3 months (i.e., complaint of sensation of burning, stabbing or pressing pain, shooting or shock like pain, or paresthesias) 3. Neuropathic Pain Symptom Inventory score ≥10. 4. self identifies as Black or Hispanic Exclusion Criteria: 1. any unstable medical condition or medical contraindication to moderate physical exertion (e.g., unstable angina or cardiac arrythmia) 2. pregnancy 3. currently taking Buprenorphine or recently stopped taking (within 1 month) 4. presence of cognitive impairment or language barrier that impairs full autonomy in the consent process or in the ability to participate in detailed interviews 5. implants in the head or neck, cochlear implants, or pacemaker 6. head or neck metastasis or recent ear trauma 7. history of seizures.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neuropathic pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Miami
Miami, Florida, 33176, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists map the daily rhythms of chronic pain
- Can zapping two brain regions at once quiet chronic nerve pain?
- Can a mindfulness app ease the stress of hospitalization?
- Zapping the brain to loosen stiff legs and quiet nerve pain in MS?
- Ancient Mind-Body practice put to the test for spinal cord injury pain
- Can a skin injection of ketamine and lidocaine tame CRPS pain?